Skip to main content

and
  1. No Access

    Article

    HIF-1-dependent heme synthesis promotes gemcitabine resistance in human non-small cell lung cancers via enhanced ABCB6 expression

    Gemcitabine is commonly used to treat various cancer types, including human non-small cell lung cancer (NSCLC). However, even cases that initially respond rapidly commonly develop acquired resistance, limiting...

    Lisha **ang, Yongsheng Wang, Jie Lan, Feifei Na in Cellular and Molecular Life Sciences (2022)